|
Resolution: standard / high Figure 2.
Comparisons of sclerostin serum levels in ankylosing spondylitis (AS) patients at
baseline, 6 months and 12 months after anti-TNF therapy and in healthy controls.
Saad et al. Arthritis Research & Therapy 2012 14:R216 doi:10.1186/ar4055 |
